CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Revenue
Total revenue	$ 1,132,067	$ 1,100,214	$ 2,820,269	$ 2,819,145
Operating expenses
Cost of product revenue	736,733	206,228	1,808,918	247,135
Research and development	1,481,166	851,608	3,843,918	3,033,851
Sales and marketing	2,716,752	663,765	7,119,204	943,908
General and administrative	2,703,628	3,070,702	8,761,776	8,512,195
Impairment of goodwill		3,648,000		3,648,000
Total operating expenses	7,638,279	8,440,303	21,533,816	16,385,089
Loss from operations	(6,506,212)	(7,340,089)	(18,713,547)	(13,565,944)
Interest expense	(872,044)	(464,684)	(2,185,868)	(800,885)
Other income (expense), net	9,540	(14,876)	322,244	(13,428)
Change in fair value of warrants and conversion option liability	26,231	388,800	(119,134)	636,121
Gain on Valeant settlement	1,204,133		1,204,133
Loss on extinguishment of debt				(207,713)
Net loss before income tax	(6,138,352)	(7,430,849)	(19,492,172)	(13,951,849)
Income tax benefit		12,190,693		12,190,693
Net income (loss)	(6,138,352)	4,759,844	(19,492,172)	(1,761,156)
Deemed dividend attributable to preferred stock			(995,000)
Net income (loss) attributable to common shareholders	$ (6,138,352)	$ 4,759,844	$ (20,487,172)	$ (1,761,156)
Net income (loss) per share, basic	$ (0.51)	$ 1.29	$ (1.91)	$ (0.94)
Net income (loss) per share, diluted	$ (0.51)	$ 1.11	$ (1.91)	$ (0.94)
Weighted-average common shares outstanding:
Basic:	12,061,672	3,695,660	10,701,977	1,883,115
Diluted:	12,061,672	4,480,235	10,701,977	1,883,115
Product revenue
Revenue
Total revenue	$ 1,132,067	$ 445,665	$ 2,642,880	$ 581,654
Collaboration revenue
Revenue
Total revenue		$ 654,549	$ 177,389	$ 2,237,491